(Q40220763)

18 September 2017

The effect of epigenetic therapy on congenital neurogenic bladders--a pilot study (English)

1 reference

18 September 2017

0 references

4

1 reference

18 September 2017

Steve J Hodges

1

1 reference

18 September 2017

James J Yoo

series ordinal

2

1 reference

18 September 2017

Nilamadhab Mishra

series ordinal

3

1 reference

18 September 2017

language of work or name

English

0 references

publication date

6 February 2010

1 reference

18 September 2017

1 reference

18 September 2017

75

1 reference

18 September 2017

4

1 reference

18 September 2017

868-872

1 reference

Epigenetic regulation of hepatic stellate cell activation

18 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2860424

Microarray analysis of bladder smooth muscle from patients with myelomeningocele

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2860424

Histone deacetylase inhibitors: understanding a new wave of anticancer agents

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2860424

Phenylbutyrate decreases type I collagen production in human lung fibroblasts

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2860424

Antimuscarinics for treatment of overactive bladder

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2860424

Emerging role of botulinum toxin in the treatment of neurogenic and non-neurogenic voiding dysfunction

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2860424

Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2860424

Electrical stimulation for the treatment of bladder dysfunction: current status and future possibilities.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2860424

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2860424

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2860424

DNA methylation and chromatin modification.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2860424

Long-term intravesical oxybutynin chloride therapy in children with myelodysplasia

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2860424

The various types of neurogenic bladder dysfunction: an update of current therapeutic concepts

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2860424

Phenotypic and functional characterization of in vivo tissue engineered smooth muscle from normal and pathological bladders

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2860424

Trichostatin A, lead compound for development of antifibrogenic drugs.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2860424

The value of urodynamic testing in the management of neonates with myelodysplasia: a prospective study

20 August 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.11.022

The urological evaluation and management of patients with myelodysplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.11.022

The long-term urological response of neonates with myelodysplasia treated proactively with intermittent catheterization and anticholinergic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.11.022

Molecular analysis of collagens in bladder fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.11.022

Type III collagen messenger RNA is modulated in non-compliant human bladder tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.11.022

10.1016/J.UROLOGY.2009.11.022

7 January 2021

Identifiers

DOI

1 reference

18 September 2017

1 reference

18 September 2017

PubMed publication ID

20138341

1 reference